In a statement to UK-based publication The Telegraph, Jennifer compared the injection to a “regular flu shot” but shared that eligibility for the trial did not come without risks. She said,
“There were a ton of risks involved. But I’m a real positive person and the benefits of this far outweighed any risks in my mind”.Jennifer Haller
During the trial, participants will receive two doses of the experimental vaccine 28 days apart followed by one year of monitoring. Being the first, Jennifer was asked to keep a daily log of any symptoms she encounters for two weeks. She told the outlet,
“The first day I had a slightly elevated temperature. The second day my arm was pretty sore. But that was it — everything was all right after that. It was as easy as a regular flu shot.”Jennifer Haller
Jennifer and 44 other adults who participated in the study will receive their second dose next week and monitoring won’t end until the spring of 2021.